Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1068 per EA under NDC 00904715661. Its NADAC has been published 245 times since Dec 15, 2021.
FDA first approved this application on Sep 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904715661
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205245FDA Approved
9/23/2015
TE Code
AB
On Market Since
11/29/2017
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 245 times since Dec 15, 2021, and over the history we have for it it has declined 8.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1068 per EA |
|---|---|
| All-time high | $0.1478 (May 11, 2022) |
| All-time low | $0.0623 (Dec 17, 2025) |
| 52-week high | $0.1070 |
| 52-week low | $0.0623 |
| Median price | $0.1070 |
| Average price | $0.1031 |
| Largest weekly change | -35.7% (Feb 21, 2024) |
| Weeks tracked | 245 |
| Tracking since | Dec 15, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1068 per EA (NDC 00904715661), effective Aug 19, 2026.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has declined 8.4%. It has been tracked across 245 weekly CMS publications since Dec 15, 2021.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Dec 15, 2021, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.1478 (May 11, 2022), with a median of $0.1070 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METRONIDAZOLE 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 00904715661) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.